Analysis and Insights
Earnings Release and Price Movement:
Legend Biotech (LEGN) is set to release its Q4 earnings on March 11, 2025, with expectations of an EPS of -$0.38 and revenue of $179M. The stock has shown positive movement today, with a pre-market increase of 1.35% and a regular market increase of 8.67%, trading at $36.98.
Technical Indicators:
The RSI for LEGN is 42.82, indicating it's not overbought. The MACD is slightly negative, suggesting bearish momentum, but today's price increase could signal a trend reversal.
Analyst Sentiment:
Analysts are bullish, with a Strong Buy rating from HC Wainwright & Co. and a Buy rating from Piper Sandler, citing high demand for Carvykti.
Conclusion:
LEGN shows upside potential, especially if earnings exceed expectations. However, caution is advised due to potential market volatility and risks.